BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36127526)

  • 1. Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric Cancer.
    Sawaki K; Kanda M; Baba H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Kodera Y
    Ann Surg Oncol; 2023 Jan; 30(1):628-636. PubMed ID: 36127526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis.
    Sasahara M; Kanda M; Tanaka C; Shimizu D; Umeda S; Takami H; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
    Int J Cancer; 2024 Apr; 154(7):1272-1284. PubMed ID: 38151776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
    Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
    Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-Aminobutyric Acid Type A Receptor Subunit Delta (
    Wu L; Zhang Y; Zheng C; Zhao F; Lin Y
    Iran J Public Health; 2023 Mar; 52(3):542-552. PubMed ID: 37124892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
    Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
    Zhao EH; Shen ZY; Liu H; Jin X; Cao H
    World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of TRPV1 ion channels in the suppression of gastric cancer development.
    Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
    J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
    Song J; Liu Y; Wang T; Li B; Zhang S
    Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research for Expression and Prognostic Value of GABRD in Colon Cancer and Coexpressed Gene Network Construction Based on Data Mining.
    Liu T; Fang Y
    Comput Math Methods Med; 2021; 2021():5544182. PubMed ID: 34194536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
    Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of long non-coding RNA DQ786243 promotes the progression of gastric cancer.
    Shan T; Fan J; Zhao Q; Deng K; Xia J
    Mol Med Rep; 2017 Oct; 16(4):3761-3768. PubMed ID: 28731138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABRD promotes progression and predicts poor prognosis in colorectal cancer.
    Niu G; Deng L; Zhang X; Hu Z; Han S; Xu K; Hong R; Meng H; Ke C
    Open Med (Wars); 2020; 15(1):1172-1183. PubMed ID: 33336074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins.
    Yuan L; Li JX; Yang Y; Chen Y; Ma TT; Liang S; Bu Y; Yu L; Nan Y
    World J Gastroenterol; 2021 Apr; 27(16):1785-1804. PubMed ID: 33967557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
    Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
    Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.
    Ding L; Zhao Y; Dang S; Wang Y; Li X; Yu X; Li Z; Wei J; Liu M; Li G
    Mol Cancer; 2019 Mar; 18(1):45. PubMed ID: 30922402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of guanylyl cyclase C in gastric cancer as a potential biomarker and therapeutic target.
    Mao ZB; Zhang JF; Xu Z; Zhu HJ; Zhang JG; Pan ZP; Xiao F; Yang JL
    J Dig Dis; 2009 Nov; 10(4):272-85. PubMed ID: 19906106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression.
    Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C
    Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.